1

1

Breakthrough innovation in the fight against pancreatic cancer

Breakthrough innovation in the fight against pancreatic cancer

CC&C is a Medtech start-up. We rely on the latest discoveries in the field of oncology and in particular physical oncology and mechanobiology, to develop a treatment against pancreatic cancer.

Our method consists in exerting a ‘Constraint Field’ -the Therapeutic Agent- on the tumor, to restore normal tissue architecture, and therefore normal functioning of the organ. In other words, it is nothing less than reversing the process of cancerization (see our Scientific Bibliography).

We are continuing our experiments on animal models and hope to manufacture a human prototype in 2019. Under optimal conditions, our development plan envisages that the device is available for experimentation in patients in 2021.

What is Cell Constraint & Cancer ?

of research

raised in 2017

before placing on the market

subscribe to our capital increase

Invest in a breakthrough innovation, unique and patented.

Development faster than a drug.

Latest news from CC&C

Test Article EN 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras at augue vel arcu semper tincidunt ut porta erat. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nullam felis ante, auctor sed pulvinar quis, cursus et turpis. Proin non commodo orci. Suspendisse...
Lire la suite

11 + 12 =

CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles

CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles